Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is capable of large‐scale transmission and has caused the coronavirus disease 2019 (COVID‐19) pandemic. Patients with COVID‐19 may experience persistent long‐term health issues, known as long COVID. Both acute SARS‐CoV‐2 infection...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2023-12-01
|
| Serie: | MedComm |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/mco2.426 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|